Physician profile

Dave Yu Chua

Cardiovascular Disease · Aurora, IL

NPI 1508807280

$1,830.14

in general payments reported to CMS, 2019-2025

16 companies · $378 in 2025

The $378 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$985.84

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $366.54 2021-2025 Cardiomems
Pfizer INC. $276.25 2019-2021
Astrazeneca Pharmaceuticals LP $189.36 2019-2024 Farxiga
Edwards Lifesciences Corporation $177.42 2024-2025 Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Janssen Pharmaceuticals, INC $175.98 2019-2021
Ancora Heart, INC. $166.43 2024 Accucinch
Actelion Pharmaceuticals US, INC. $116.78 2025 Uptravi, Opsumit
Regeneron Healthcare Solutions, INC. $81.15 2022
Kestra Medical Technology Services, INC. $79.60 2024 Assure Wcd
Heartflow, INC. $70.62 2025
Akcea Therapeutics, INC. $52.33 2019
Lantheus Medical Imaging, INC. $20.69 2023 Definity
Tactile Systems Technology INC $20.04 2019
Echosens North America, INC. $13.40 2025 Fibroscan
Boston Scientific Corporation $11.83 2022
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Sanofi-Aventis U.S. LLC $11.72 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dave Yu Chua

$1,830.14

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $378 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/405876/dave-yu-chua

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.